(Q47645409)

4 February 2018

title

Induction of antitumour immunity using survivin peptide-pulsed dendritic cells in a murine lymphoma model. (English)

1 reference

4 February 2018

1 reference

Sandra Siegel

1

1 reference

4 February 2018

Andreas Wagner

series ordinal

2

1 reference

4 February 2018

Norbert Schmitz

series ordinal

3

1 reference

4 February 2018

Matthias Zeis

series ordinal

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 September 2003

1 reference

4 February 2018

British Journal of Haematology

published in

1 reference

4 February 2018

volume

122

1 reference

4 February 2018

issue

6

1 reference

4 February 2018

page(s)

911-914

1 reference

4 February 2018

Expression and prognostic significance of survivin in de novo acute myeloid leukaemia

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04535.X

Cytokine-regulated expression of survivin in myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04535.X

Regulation of the inhibitor-of-apoptosis family member survivin in normal cord blood and bone marrow CD34(+) cells by hematopoietic growth factors: implication of survivin expression in normal hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04535.X

Survivin expression correlates with apoptosis resistance after lymphocyte activation and is found preferentially in memory T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04535.X

Idiotype protein-pulsed dendritic cells produce strong anti-myeloma effects after syngeneic stem cell transplantation in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2141.2003.04535.X

10.1046/J.1365-2141.2003.04535.X

21 January 2018

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

12956760

1 reference

4 February 2018